Scarce data on skin microbiome in graft-versus-host disease after allogenic haematopoietic cell transplantation - a systematic review

M Schumacher¹, A Egli^{2

3}, A Mari^{2

3}, A A Navarini¹, J P Halter⁴, S M Müller¹

Affiliations

¹ Dermatology, Division of Theragnostics, University Hospital Basel, Basel, Switzerland.
² Clinical Bacteriology and Mycology, University Hospital Basel, Basel, Switzerland.
³ Applied Microbiology Research, Department of Biomedicine, University of Basel, Basel, Switzerland.
⁴ Hematology, University Hospital Basel, Basel, Switzerland.

M Schumacher et al. J Eur Acad Dermatol Venereol. 2022 May.

. 2022 May;36(5):e357-e359.

doi: 10.1111/jdv.17869. Epub 2021 Dec 27.

M Schumacher¹, A Egli^{2

3}, A Mari^{2

3}, A A Navarini¹, J P Halter⁴, S M Müller¹

¹ Dermatology, Division of Theragnostics, University Hospital Basel, Basel, Switzerland.
² Clinical Bacteriology and Mycology, University Hospital Basel, Basel, Switzerland.
³ Applied Microbiology Research, Department of Biomedicine, University of Basel, Basel, Switzerland.
⁴ Hematology, University Hospital Basel, Basel, Switzerland.

No abstract available

References

1. Lee SJ, Nguyen TD, Onstad L et al. Success of immunosuppressive treatments in patients with chronic graft-versus-host disease. Biol Blood Marrow Transplant 2018; 24: 555-562.
1. Strong Rodrigues K, Oliveira-Ribeiro C, de Abreu Fiuza Gomes S, Knobler R. Cutaneous graft-versus-host disease: diagnosis and treatment. Am J Clin Dermatol 2018; 19: 33-50.
1. Schluter J, Peled JU, Taylor BP et al. The gut microbiota is associated with immune cell dynamics in humans. Nature 2020; 588: 303-307.
1. Santos ESP, Bennett CL, Chakraverty R. Unraveling the mechanisms of cutaneous graft-versus-host disease. Front Immunol 2018; 9: 963.
1. Gu Y, Sun J, Li K, Wu X, Zhang J. Alteration in the skin microbiome in cutaneous graft versus host disease. Acta Derm Venereol 2021; 101: adv00374.